fxyz

AI speeds up drug discovery, biotech wins

AI will make drug discovery much faster and wider, and biotech companies will be the big winners.

Result

If held over the last 3 months (Aug 6, 2026 – Nov 5, 2026): −0.2%. Over the same days: S&P 500 −0.4%, Chip stocks −11.5%.

What it holds

  • Broad biotech, 23% of the money, −6.4% over 3 months: XBI (SPDR S&P Biotech ETF). If AI finds more drugs faster, many small biotech firms get a boost.
  • Platform biotechs, 18% of the money, +15.6% over 3 months: MRNA (Moderna), TWST (Twist Bioscience). Firms with fast, flexible tech can use AI to make new products quicker.
  • Big drug makers, 18% of the money, +21.6% over 3 months: LLY (Eli Lilly). Large drug firms have the money and data to turn AI into real drugs.
  • AI brains and chips, 23% of the money, −13.4% over 3 months: NVDA (Nvidia), GOOGL (Alphabet (Google)). The AI itself needs powerful chips and smart models, and those sellers get paid.
  • Science on crypto, 9% of the money, −12.3% over 3 months: BIO (Bio Protocol). Crypto projects that fund science could get attention if AI biotech takes off.
  • Cash, 10%.

The plan behind it

If AI cuts years off finding new medicines, the payoff goes to a few groups. One is the broad biotech sector. Another is companies with strong platforms that AI can plug into, like mRNA and DNA-making firms. A third is big drug makers who can test and sell many more drugs. The last is the firms building the AI brains and chips. I also added a small bet on a crypto coin tied to science projects. Everything is long, because the bet is that AI lifts the whole field.

What would prove it wrong: AI-designed drugs keep failing in human trials and the big drug firms say AI isn't cutting time or cost.

FAQ

How do I bet that AI will make drug discovery much faster and wider, and biotech companies will be the big winners?

This tested idea holds XBI (SPDR S&P Biotech ETF), MRNA (Moderna), TWST (Twist Bioscience), LLY (Eli Lilly), NVDA (Nvidia), GOOGL (Alphabet (Google)) and BIO (Bio Protocol), with 10% in cash. Make a copy to run it on practice money first, at real prices.

What would prove it wrong?

AI-designed drugs keep failing in human trials and the big drug firms say AI isn't cutting time or cost.

Can I make one from my own idea?

Yes. Write what you believe in plain words at https://f.xyz/create. fxyz asks a couple of questions, builds the portfolio and shows how it would have done over the last 3 months.

Can I turn a post on X into a theory?

Yes. Reply to the post and tag @fxyzai. It tests the view in the post and replies with the 3-month result and a link.

What can it trade?

Stocks (Tesla, Apple, Nvidia), crypto (Bitcoin, Ethereum, Solana), pre-IPO companies (OpenAI, Anthropic), indices (Nasdaq 100, S&P 500), commodities (gold, silver, oil, copper) and currencies (EUR/USD, USD/JPY). One theory can mix them, and bet for or against any of them.

How does it react to news?

On each check it reads the last two days of news on its biggest holdings and says whether the idea still holds. It can make one small change at a time: trim or drop one holding by up to 5 points. On autopilot the change waits 10 minutes so the owner can skip it; otherwise it asks first.

How do I run it with real money?

For real money, tap Make it mine, open your copy and choose Use real money, with an exchange connected: Hyperliquid, Lighter, Lighter (Robinhood), Backpack, Pacifica or Binance. The money stays in your own account there. fxyz can place trades, but it can never withdraw.

Can the AI get it wrong?

Yes. fxyz's AI turns the idea into holdings, and it can get that wrong: add a coin or stock that doesn't fit, or miss one that does. Check the holdings before you put money in. In your own copy, ask its chat to add or drop any of them.

What do the 3-month numbers mean?

What $100 would have done holding this mix over the last 3 months, at real prices. It is a what-if, not a record: past or simulated results are no promise of future ones, and nothing here is investment advice.

Test your own idea on fxyz · More theories